Decisio Funding: How Much Did They Raise & Key Investors

How Much Did Decisio Raise?
Funding & Key Investors

Decisio has solidified its position in the health-tech sector, securing a total capital infusion of $25.9M to date. This trajectory of financial backing, punctuated by a recent strategic investment of $18.5M, underscores the firm's growing influence in the clinical surveillance landscape. By leveraging these resources, the Houston-based enterprise is poised to accelerate its operational footprint and enhance its data visualization capabilities for healthcare providers.

The company's funding history reflects a disciplined approach to growth, beginning with initial private equity support in early 2016, followed by a Series A round later that same year. Subsequent debt financing in 2017 provided the necessary liquidity to bridge toward its most recent Series B milestone, signaling strong investor confidence in its long-term market viability.

What is Decisio?

Decisio

Software

Healthcare Software

Decisio Health operates at the intersection of clinical informatics and real-time data analytics. Founded in 2013, the company specializes in sophisticated software solutions designed for clinical surveillance and high-fidelity data visualization. By transforming complex patient data into actionable insights, Decisio enables medical professionals to monitor patient status more effectively, thereby improving clinical outcomes and operational efficiency within hospital environments. Its market position is defined by its ability to integrate disparate data streams into a unified, intuitive interface, a critical requirement for modern enterprise-level healthcare systems.

How much funding has Decisio raised?

Decisio has raised a total of $25.9M across 4 funding rounds:

2016

Private Equity

$2.2M

Series A

$4.5M

2017

Debt

$737K

2022

Series B

$18.5M

Private Equity (2016): $2.2M, investors not publicly disclosed

Series A (2016): $4.5M, investors not publicly disclosed

Debt (2017): $737K, investors not publicly disclosed

Series B (2022): $18.5M, investors not publicly disclosed

Key Investors in Decisio

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for Decisio?

With the successful closure of its latest financing round, Decisio is entering a critical phase of enterprise-level scaling. The strategic deployment of this capital will likely focus on expanding its software-as-a-service (SaaS) infrastructure and deepening its integration capabilities with existing electronic health record (EHR) systems. As the demand for real-time clinical decision support tools continues to rise, Decisio is well-positioned to capture additional market share. Future growth initiatives will likely prioritize product innovation, specifically in predictive analytics and automated reporting, to maintain its competitive edge in the rapidly evolving digital health ecosystem.

See full Decisio company page

See More Financial Insights